Phyllis L. Panzeter
- Co-authors
- Felix R. AlthausClaudio RealiniMaria MalangaMargaret A. CollingeStephan Alexander BraunLiane HöffererHanna E. KleczkowskaDavid P. Ringer
- Topics
- PARP inhibition in cancer therapy (11 papers)DNA Repair Mechanisms (8 papers)Cancer therapeutics and mechanisms (4 papers)
- Cited by
- PhysiologyOncologyImmunology
- Partner nations
- SwitzerlandUnited StatesFrance
In The Last Decade
Phyllis L. Panzeter
17 papers receiving 560 citations
Peers
Comparison fields: 5 of 58
- Oncology 485
- Molecular Biology 380
- Immunology 171
- Physiology 103
- Electrical and Electronic Engineering 64
Countries citing papers authored by Phyllis L. Panzeter
This map shows the geographic impact of Phyllis L. Panzeter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phyllis L. Panzeter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phyllis L. Panzeter more than expected).
Fields of papers citing papers by Phyllis L. Panzeter
This network shows the impact of papers produced by Phyllis L. Panzeter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phyllis L. Panzeter. The network helps show where Phyllis L. Panzeter may publish in the future.
Co-authorship network of co-authors of Phyllis L. Panzeter
This figure shows the co-authorship network connecting the top 25 collaborators of Phyllis L. Panzeter. A scholar is included among the top collaborators of Phyllis L. Panzeter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phyllis L. Panzeter. Phyllis L. Panzeter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 29 | |
| 4 | 25 | |
| 5 | 55 | |
| 6 | 8 | |
| 7 | 69 | |
| 8 | 29 | |
| 9 | 53 | |
| 10 | 19 | |
| 11 | 58 | |
| 12 | 31 | |
| 13 | 110 | |
| 14 | 10 | |
| 15 | 3 | |
| 16 | 62 | |
| 17 | 5 |
About Phyllis L. Panzeter
Phyllis L. Panzeter is a scholar working on Oncology, Physiology and Molecular Biology, having authored 17 papers that have together received 570 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (11 papers), DNA Repair Mechanisms (8 papers) and Cancer therapeutics and mechanisms (4 papers). The work is most often cited by research in Physiology (103 citations), Oncology (485 citations) and Immunology (171 citations). Phyllis L. Panzeter has collaborated with scholars based in Switzerland, United States and France. Frequent co-authors include Felix R. Althaus, Claudio Realini, Maria Malanga, Margaret A. Collinge, Stephan Alexander Braun, Liane Höfferer, Hanna E. Kleczkowska, David P. Ringer, Hanspeter Naegeli and M. J. Richard. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.